Cyclin D1: polymorphism, aberrant splicing and cancer risk

Karen E. Knudsen(University of Cincinnati Medical Center), J. Alan Diehl(UPMC Hillman Cancer Center), C.A. Haiman(University of Southern California), Erik S. Knudsen(University of Cincinnati)
Oncogene
March 13, 2006
10.1038/sj.onc.1209371
Cited by 359

Abstract

Related Papers

β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Osamu Tetsu, Frank McCormick|Nature|1999|3.6k
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
Jun‐ya Kato, H Matsushime, Scott W. Hiebert et al.|Genes & Development|1993|1.3k
D-type cyclin-dependent kinase activity in mammalian cells.
H Matsushime, Dawn E. Quelle, Sheila Shurtleff et al.|Molecular and Cellular Biology|1994|1.1k
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
Philip W. Hinds, Sibylle Mittnacht, Vjekoslav Dulić et al.|Cell|1992|1k
Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
J. Alan Diehl, Frédérique Zindy, Charles J. Sherr|Genes & Development|1997|748